GlaxoSmithKline Consumer Healthcare, which declared its financial results for the 15-month period ended March 31, 2014, posted net sales of ₹4,683 crore. The company’s net profit stood at ₹675 crore for this period.
In a BSE filing, the company said: “The accounting year of the company has been changed from January-December to April-March. Accordingly, the current year’s financial statements are for a period of 15 months, from January 1, 2013, to March 31, 2014. These figures are not comparable with those of the previous year ended December 31, 2012.”
For the quarter ended March 31, 2014, the company posted net profit of ₹171.7 crore, up from ₹156.40 crore for the corresponding quarter last year.
Total income for the quarter stood at ₹1,167.82 crore, up from ₹1,007.8 crore for the quarter ended March 31, 2013. The board recommended a dividend at ₹45 a share (equity share of ₹10 each) for the 15-month period.